Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Apr 1, 2023
Revenue declined in the quarter versus both the immediately preceding period and the same quarter last year. The sequential and annual decreases reflect a clear downward trajectory.
Key takeaway
Quarter ended Apr 1, 2023 · FY2023 Q1
Revenue declined in the quarter versus both the immediately preceding period and the same quarter last year. The sequential and annual decreases reflect a clear downward trajectory.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.7B
Revenue reported for this quarter.
Quarter-over-quarter
-6.5%
Change from the immediately preceding quarter.
Year-over-year
-9.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$43.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jul 2, 2022 | $11B | +18.3% |
| Oct 1, 2022 | $10.7B | +14.4% |
| Dec 31, 2022 | $11.5B | +7.0% |
| Apr 1, 2023 | $10.7B | -9.4% |
Revenue performance
The reported revenue for the quarter was lower than the prior quarter, marking a sequential decline. Compared with the same quarter a year earlier, revenue was also down.
Quarterly comparison
Sequentially, revenue fell from the immediately preceding quarter. On an annual basis, the quarter's revenue was below the level reported for the same quarter one year earlier.
What to watch
Revenue has now declined year over year for the first time in the supplied trend series, following several quarters of growth.